Peregrine Pharma (PPHM) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Research and development: 8.57M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 8.57M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q2 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $5.68 million versus the consensus estimate of $4.23 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Exclusive: BitGo says institutional conversations are shifting to tokenization
- Pulmatrix (PULM) Reports Q2 Loss of $0.29
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
